195 IMMUNE THROMBOCYTOPENIA IN MYELODYSPLASTIC SYNDROME WHICH WAS REFRACTORY TO ELTROMBOPAG WAS TREATED SUCCESSFULLY WITH RITUXIMAB. Issue 1 (April 2015)